Details for New Drug Application (NDA): 072191
✉ Email this page to a colleague
NDA 072191 describes CLOFIBRATE, which is a drug marketed by Banner Pharmacaps, Sandoz, Teva, Usl Pharma, and Watson Labs, and is included in five NDAs. Additional details are available on the CLOFIBRATE profile page.
The generic ingredient in CLOFIBRATE is clofibrate. There are four drug master file entries for this compound. Additional details are available on the clofibrate profile page.
The generic ingredient in CLOFIBRATE is clofibrate. There are four drug master file entries for this compound. Additional details are available on the clofibrate profile page.
Summary for 072191
| Tradename: | CLOFIBRATE |
| Applicant: | Sandoz |
| Ingredient: | clofibrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072191
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
| Approval Date: | May 2, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
